The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
COX-2 and beyond: approaches to prostaglandin inhibition in human disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,917
Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2692 · Cited by 1,707
The Coxibs, Selective Inhibitors of Cyclooxygenase-2
FitzGerald, G. A., & Patrono, C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108093450607 · Cited by 1,565
Self-citationThun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
Self-citationMcAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Self-citationYamagata, K., Andreasson, K. I., Kaufmann, W. E., Barnes, C. A., & Worley, P. F. (1993) · Neuron · doi:10.1016/0896-6273(93)90192-t · Cited by 1,226
The way I see it: House officers need formal career development
Connor, A. (2002) · BMJ · doi:10.1136/bmj.324.7336.s71 · Cited by 1,143
Platelet Activation in Unstable Coronary Disease
Fitzgerald, D. J., Roy, L., Catella, F., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151602 · Cited by 1,141
Self-citationPatrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
Self-citationPatrignani, P., Filabozzi, P., & Patrono, C. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110576 · Cited by 937
Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesisa
GIMBRONE, M. A., TOPPER, J. N., NAGEL, T., ANDERSON, K. R., & GARCIA‐CARDEÑA, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06318.x · Cited by 836
cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.
O'Banion, M. K., Winn, V. D., & Young, D. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4888 · Cited by 821
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
Cheng, Y., Austin, S. C., Rocca, B., Koller, B. H., Coffman, T. M., Grosser, T., Lawson, J. A., & FitzGerald, G. A. (2002) · Science · doi:10.1126/science.1068711 · Cited by 789
Self-citationAltered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Tanioka, T., Nakatani, Y., Semmyo, N., Murakami, M., & Kudo, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003504200 · Cited by 708 · cited 1×
“, or of the cytoplasmic isoform, linked to COX-1 (Ref”
BackgroundCyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Teismann, P., Tieu, K., Choi, D.-K., Wu, D.-C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 660
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18162 · Cited by 634
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2
Luong, C., Miller, A., Barnett, J., Chow, J., Ramesha, C., & Browner, M. F. (1996) · Nature Structural Biology · doi:10.1038/nsb1196-927 · Cited by 618
Catella-Lawson, F., McAdam, B., Morrison, B. W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K. C., Quan, H., Gertz, B. J., & Fitzgerald, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 597
Self-citationGenetic and pharmacological analysis of prostanoid receptor function
Narumiya, S., & FitzGerald, G. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13455 · Cited by 568
Self-citationImpaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase
Trebino, C. E., Stock, J. L., Gibbons, C. P., Naiman, B. M., Wachtmann, T. S., Umland, J. P., Pandher, K., Lapointe, J.-M., Saha, S., Roach, M. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332766100 · Cited by 552
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease
Ray, W. A., Stein, C. M., Daugherty, J. R., Hall, K., Arbogast, P. G., & Griffin, M. R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11131-7 · Cited by 503
Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet Activation
FitzGerald, G. A., Smith, B., Pedersen, A. K., & Brash, A. R. (1984) · New England Journal of Medicine · doi:10.1056/nejm198404263101701 · Cited by 497
Self-citationGenetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.
Chulada, P. C., Thompson, M. B., Mahler, J. F., Doyle, C. M., Gaul, B. W., Lee, C., Tiano, H. F., Morham, S. G., Smithies, O., & Langenbach, R. J. (2000) · PubMed · Cited by 496
Loll, P. J., Picot, D., & Garavito, R. M. (1995) · Nature Structural Biology · doi:10.1038/nsb0895-637 · Cited by 490
Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.
FitzGerald, G. A., Pedersen, A. K., & Patrono, C. (1983) · Circulation · doi:10.1161/01.cir.67.6.1174 · Cited by 466
Self-citationReid, G., Wielinga, P., Zelcer, N., van der Heijden, I., Kuil, A., de Haas, M., Wijnholds, J., & Borst, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1033060100 · Cited by 463
The Relationship Between Cyclooxygenase-2 Expression and Colorectal Cancer
Sheehan, K. M. (1999) · JAMA · doi:10.1001/jama.282.13.1254 · Cited by 461
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease
Rich, J. B., Rasmusson, D. X., Folstein, M. F., Carson, K. A., Kawas, C., & Brandt, J. (1995) · Neurology · doi:10.1212/wnl.45.1.51 · Cited by 446
Reilly, I., & FitzGerald, G. (1987) · Blood · doi:10.1182/blood.v69.1.180.180 · Cited by 419
Self-citationEffect of ibuprofen on cardioprotective effect of aspirin
MacDonald, T., & Wei, L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12509-3 · Cited by 419
Ott, E., Nussmeier, N. A., Duke, P. C., Feneck, R. O., Alston, R. P., Snabes, M. C., Hubbard, R. C., Hsu, P. H., Saidman, L. J., & Mangano, D. T. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(03)00125-9 · Cited by 403
Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene.
Kujubu, D. A., & Herschman, H. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42398-8 · Cited by 402
Jüni, P., Rutjes, A. W., & Dieppe, P. A. (2002) · BMJ · doi:10.1136/bmj.324.7349.1287 · Cited by 396
Salt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor
Kennedy, C. R. J., Zhang, Y., Brandon, S., Guan, Y., Coffee, K., Funk, C. D., Magnuson, M. A., Oates, J. A., Breyer, M. D., & Breyer, R. M. (1999) · Nature Medicine · doi:10.1038/5583 · Cited by 391
Shinmura, K., Tang, X.-L., Wang, Y., Xuan, Y.-T., Liu, S.-Q., Takano, H., Bhatnagar, A., & Bolli, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10197 · Cited by 381
Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions
Schönbeck, U., Sukhova, G. K., Graber, P., Coulter, S., & Libby, P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65230-3 · Cited by 379
Cyclooxygenase-1 and -2–Dependent Prostacyclin Formation in Patients With Atherosclerosis
Belton, O., Byrne, D., Kearney, D., Leahy, A., & Fitzgerald, D. J. (2000) · Circulation · doi:10.1161/01.cir.102.8.840 · Cited by 377
Adderley, S. R., & Fitzgerald, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5038 · Cited by 371
Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease
Chenevard, R., Hürlimann, D., Béchir, M., Enseleit, F., Spieker, L., Hermann, M., Riesen, W., Gay, S., Gay, R. E., Neidhart, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000051361.69808.3a · Cited by 358
van Hecken, A., Schwartz, J. I., Depré, M., de Lepeleire, I., Dallob, A., Tanaka, W., Wynants, K., Buntinx, A., Arnout, J., Wong, P. H., et al. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/009127000004001005 · Cited by 354
Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonists
FitzGerald, G. A. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90379-y · Cited by 353
Self-citationCardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib
Konstam, M. A., Weir, M. R., Reicin, A., Shapiro, D., Sperling, R. S., Barr, E., & Gertz, B. J. (2001) · Circulation · doi:10.1161/hc4401.100078 · Cited by 352
Cipollone, F., Prontera, C., Pini, B., Marini, M., Fazia, M., De Cesare, D., Iezzi, A., Ucchino, S., Boccoli, G., Saba, V., et al. (2001) · Circulation · doi:10.1161/hc3401.093152 · Cited by 351
Murakami, M., Nakashima, K., Kamei, D., Masuda, S., Ishikawa, Y., Ishii, T., Ohmiya, Y., Watanabe, K., & Kudo, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305108200 · Cited by 344
Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ
Bell-Parikh, L. C., Ide, T., Lawson, J. A., McNamara, P., Reilly, M., & FitzGerald, G. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18012 · Cited by 341
Self-citationProstaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor
Takayama, K., Garcı́a-Cardeña, G., Sukhova, G. K., Comander, J., Gimbrone, M. A., & Libby, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204810200 · Cited by 337
Ray, W. A., Stein, C. M., Hall, K., Daugherty, J. R., & Griffin, M. R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07370-1 · Cited by 326
Wong, S. C. Y., Fukuchi, M., Melnyk, P., Rodger, I., & Giaid, A. (1998) · Circulation · doi:10.1161/01.cir.98.2.100 · Cited by 322
The Productive Conformation of Arachidonic Acid Bound to Prostaglandin Synthase
Malkowski, M. G., Ginell, S. L., Smith, W. L., & Garavito, R. M. (2000) · Science · doi:10.1126/science.289.5486.1933 · Cited by 308
Mamdani, M., Rochon, P., Juurlink, D. N., Anderson, G. M., Kopp, A., Naglie, G., Austin, P. C., & Laupacis, A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.481 · Cited by 281
Weggen, S., Eriksen, J. L., Sagi, S. A., Pietrzik, C. U., Ozols, V., Fauq, A., Golde, T. E., & Koo, E. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303592200 · Cited by 280
Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice
Burleigh, M. E., Babaev, V. R., Oates, J. A., Harris, R. C., Gautam, S., Riendeau, D., Marnett, L. J., Morrow, J. D., Fazio, S., & Linton, M. F. (2002) · Circulation · doi:10.1161/01.cir.0000014927.74465.7f · Cited by 279
Kurth, T., Glynn, R. J., Walker, A. M., Chan, K. A., Buring, J. E., Hennekens, C. H., & Gaziano, J. M. (2003) · Circulation · doi:10.1161/01.cir.0000087593.07533.9b · Cited by 254
McAdam, B. F., Mardini, I. A., Habib, A., Burke, A., Lawson, J. A., Kapoor, S., & FitzGerald, G. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9523 · Cited by 253
Self-citationOpposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II
Qi, Z., Hao, C., Langenbach, R. I., BREYER, R. M., Redha, R., Morrow, J. D., & Breyer, M. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14752 · Cited by 249
Watson, D. J., Rhodes, T., Cai, B., & Guess, H. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1105 · Cited by 238
Cayatte, A. J., Du, Y., Oliver-Krasinski, J., Lavielle, G., Verbeuren, T. J., & Cohen, R. A. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.7.1724 · Cited by 237
Nonsteroidal Anti-inflammatory Drug Use and Acute Myocardial Infarction
Solomon, D. H., Glynn, R. J., Levin, R., & Avorn, J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1099 · Cited by 234
Developmental expression of functional cyclooxygenases in zebrafish
Grosser, T., Yusuff, S., Cheskis, E., Pack, M. A., & FitzGerald, G. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112217799 · Cited by 216
Self-citationPraticò, D., Tillmann, C., Zhang, Z.-B., Li, H., & FitzGerald, G. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061607398 · Cited by 215
Self-citationOpposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II
Qi, Z., Hao, C.-M., Langenbach, R. I., Breyer, R. M., Redha, R., Morrow, J. D., & Breyer, M. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214752 · Cited by 210
Xiao, C.-Y., Hara, A., Yuhki, K.-I., Fujino, T., Ma, H., Okada, Y., Takahata, O., Yamada, T., Murata, T., Narumiya, S., et al. (2001) · Circulation · doi:10.1161/hc4301.098058 · Cited by 197
Schuster, V. L. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00061-8 · Cited by 182
Claveau, D., Sirinyan, M., Guay, J., Gordon, R., Chan, C.-C., Bureau, Y., Riendeau, D., & Mancini, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4738 · Cited by 180
Frequency of Analgesic Use and Risk of Hypertension in Younger Women
Curhan, G. C., Willett, W. C., Rosner, B., & Stampfer, M. J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2204 · Cited by 179
García Rodríguez, L. A., Varas, C., & Patrono, C. (2000) · Epidemiology · doi:10.1097/00001648-200007000-00004 · Cited by 177
Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema
Frishman, W. H. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02233-6 · Cited by 175
Fabre, J.-E., Nguyen, M., Athirakul, K., Coggins, K., McNeish, J. D., Austin, S., Parise, L. K., FitzGerald, G. A., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10881 · Cited by 172
Self-citationAgdeppa, E. D., Kepe, V, Petri, A., Satyamurthy, N., Liu, J., Huang, S.-C., Small, G. W., Cole, G. M., & Barrio, J. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00907-7 · Cited by 172
Cyclooxygenase-2 in Human and Experimental Ischemic Proliferative Retinopathy
Sennlaub, F., Valamanesh, F., Vazquez-Tello, A., El-Asrar, A. M., Checchin, D., Brault, S., Gobeil, F., Beauchamp, M. H., Mwaikambo, B., Courtois, Y., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080735.93327.00 · Cited by 161
&NA; (2002) · Journal of Hypertension · doi:10.1097/00004872-200212000-00001 · Cited by 160
Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo
Dowd, N. P., Scully, M., Adderley, S. R., Cunningham, A. J., & Fitzgerald, D. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11334 · Cited by 159
Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo
Dowd, N. P., Scully, M., Adderley, S. R., Cunningham, A. J., & Fitzgerald, D. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111334 · Cited by 159
Short- and Long-Term COX-2 Inhibition Reverses Endothelial Dysfunction in Patients With Hypertension
Widlansky, M. E., Price, D. T., Gokce, N., Eberhardt, R. T., Duffy, S. J., Holbrook, M., Maxwell, C., Palmisano, J., Keaney, J. F., Morrow, J. D., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000084603.93510.28 · Cited by 158
Gerritsen, M. E., & Cheli, C. D. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111125 · Cited by 154
Crofford, L. J., Oates, J. C., McCune, W. J., Gupta, S., Kaplan, M. J., Catella-Lawson, F., Morrow, J. D., McDonagh, K. T., & Schmaier, A. H. (2000) · Arthritis & Rheumatism · Cited by 152
Cyclooxygenase 2 and the kidney
Breyer, M. D., & Harris, R. C. (2001) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200101000-00014 · Cited by 145
Prostacyclin Receptor-dependent Modulation of Pulmonary Vascular Remodeling
Hoshikawa, Y., Voelkel, N. F., Gesell, T., MOORE, M. D., Morris, K. G., Alger, L., Narumiya, S., & Geraci, M. W. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.2.2010150 · Cited by 145
Cipollone, F., Fazia, M. L., Iezzi, A., Zucchelli, M., Pini, B., Cesare, D. D., Ucchino, S., Spigonardo, F., Bajocchi, G., Bei, R., et al. (2003) · Circulation · doi:10.1161/01.cir.0000056530.03783.81 · Cited by 143
Ray, W. A., Stein, C., & Halla, K. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00687-6 · Cited by 140
Xiang, Z., Ho, L., Yemul, S., Zhao, Z., Pompl, P. N., Kelley, K. A., Dang, A., Qing, W., Teplow, D. B., & Pasinetti, G. M. (2002) · Gene Expression · doi:10.3727/000000002783992352 · Cited by 133
COX-2 is not involved in thromboxane biosynthesis by activated human platelets.
Patrignani, P., Sciulli, M. G., Manarini, S., Santini, G., Cerletti, C., & Evangelista, V. (1999) · PubMed · Cited by 115
Reilly, I. A. G., Doran, J., Smith, B., & FitzGerald, G. A. (1986) · Circulation · doi:10.1161/01.cir.73.6.1300 · Cited by 111
Self-citationMechanism of cyclooxygenase-2 upregulation in late preconditioning
Xuan, Y., Guo, Y., Zhu, Y., Han, H., Langenbach, R., Dawn, B., & Bolli, R. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00076-2 · Cited by 100
Relative risk of cardiovascular events in patients with rheumatoid arthritis
DeMaria, A. N. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02235-x · Cited by 97
Vane, J. R. (2002) · Science · doi:10.1126/science.1071702 · Cited by 95
Fitzgerald, D. J., Fragetta, J., & FitzGerald, G. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113784 · Cited by 91
Self-citationChavez, M. L., & DeKorte, C. J. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80110-8 · Cited by 88
Hypoxic Induction of Cox-2 Regulates Proliferation of Human Pulmonary Artery Smooth Muscle Cells
Yang, X., Sheares, K. K. K., Davie, N. J., Upton, P. D., Taylor, G. W., Horsley, J., Wharton, J., & Morrell, N. W. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0067oc · Cited by 86
Kojima, F., Naraba, H., Sasaki, Y., Okamoto, R., Koshino, T., & Kawai, S. (2002) · PubMed · Cited by 86
Clinical pharmacology of etoricoxib: a novel selective COX-2 inhibitor
Patrignani, P., Capone, M. L., & Tacconelli, S. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.2.265 · Cited by 84
Parsing an enigma: the pharmacodynamics of aspirin resistance
FitzGerald, G. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12560-3 · Cited by 80
Self-citationRott, D., Zhu, J., Burnett, M. S., Zhou, Y., Zalles-Ganley, A., Ogunmakinwa, J., & Epstein, S. E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00304-8 · Cited by 80
TP receptor-mediated vasoconstriction in microperfused afferent arterioles: roles of O2−and NO
Schnackenberg, C. G., Welch, W. J., & Wilcox, C. S. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.2.f302 · Cited by 78
COX-2–Dependent Cardiac Failure in Gh/tTG Transgenic Mice
Zhang, Z., Vezza, R., Plappert, T. A., McNamara, P., Lawson, J. A., Austin, S. C., Praticò, D., Sutton, M. S.-J., & FitzGerald, G. A. (2003) · Circulation Research · doi:10.1161/01.res.0000071749.22027.45 · Cited by 77
Self-citationArmstrong, E. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)90003-8 · Cited by 76
The risk of cardiovascular thrombotic events with selective cyclooxygenase‐2 inhibitors
Strand, V., & Hochberg, M. C. (2002) · Arthritis Care & Research · doi:10.1002/art.10560 · Cited by 76
Use of nonsteroidal anti‐inflammatory drugs and the risk of first‐time acute myocardial infarction
Schlienger, R. G., Jick, H., & Meier, C. R. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01637.x · Cited by 75
Bulut, D., Liaghat, S., Hanefeld, C., Koll, R., Miebach, T., & gge, A. M. U. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00015 · Cited by 65
Effects of low‐dose aspirin on endothelial function in hypertensive patients
Monobe, H., Yamanari, H., Nakamura, K., & Ohe, T. (2001) · Clinical Cardiology · doi:10.1002/clc.4960241104 · Cited by 64
Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man.
Roy, L., Knapp, H. R., Robertson, R. M., & FitzGerald, G. A. (1985) · Circulation · doi:10.1161/01.cir.71.3.434 · Cited by 64
Self-citationRole of EP2and EP3PGE2receptors in control of murine renal hemodynamics
Audoly, L., Ruan, X., Wagner, V. A., Goulet, J. L., Tilley, S. L., Koller, B. H., Coffman, T. M., & Arendshorst, W. J. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.1.h327 · Cited by 55
Corrigendum to “Prostaglandin and leukotriene ω-hydroxylases”
Kikuta, Y., Kusunose, E., & Kusunose, M. (2003) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00135-1 · Cited by 53
Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin.
Braden, G. A., Knapp, H. R., & FitzGerald, G. A. (1991) · Circulation · doi:10.1161/01.cir.84.2.679 · Cited by 52
Self-citationDeficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition
Athirakul, K., Kim, H., Audoly, L., Smithies, O., & Coffman, T. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00072.x · Cited by 49
No Effect of Cyclooxygenase Inhibition on Plaque Size in Atherosclerosis-prone Mice
Olesen, M., Kwong, E. C., Meztli, A., Kontny, F. P., Seljeflot, I., Arnesen, H., Lyngdorf, L. G., & Falk, E. (2002) · Scandinavian Cardiovascular Journal · doi:10.1080/140174302762659094 · Cited by 47
Baber, S. R., Champion, H. C., Bivalacqua, T. J., Hyman, A. L., & Kadowitz, P. J. (2003) · Circulation · doi:10.1161/01.cir.0000084536.87322.bb · Cited by 46
Angiotensin II/prostaglandin I2 interactions in spontaneously hypertensive rats.
Jackson, E. K., & Herzer, W. A. (1993) · Hypertension · doi:10.1161/01.hyp.22.5.688 · Cited by 35
Modulation of Aspirin-Insensitive Eicosanoid Biosynthesis by 6-Methylprednisolone in Unstable Angina
Cipollone, F., Ganci, A., Greco, A., Panara, M. R., Pasquale, M., Gregorio, D. D., Porreca, E., Mezzetti, A., Cuccurullo, F., & Patrignani, P. (2003) · Circulation · doi:10.1161/01.cir.0000043260.82447.62 · Cited by 34
The choreography of cyclooxygenases in the kidney
FitzGerald, G. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216044 · Cited by 30
Self-citationHistamine-induced chloride secretion is mediated via H 2 -receptors in the pig proximal colon
Ahrens, R., Gäbel, G., Garz, B., & Aschenbach, J. R. (2003) · Inflammation Research · doi:10.1007/s000110300005 · Cited by 27
Gurley, S. B., Le, T. H., & Coffman, T. M. (2002) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2002.67.451 · Cited by 18
Prostaglandin F2αReceptor-Dependent Regulation of Prostaglandin Transport
Vezza, R., Rokach, J., & FitzGerald, G. A. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1506 · Cited by 14
Self-citationAisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5
Cited by
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A., Wittes, J., Fowler, R., Finn, P., Anderson, W. F., Zauber, A., Hawk, E., & Bertagnolli, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050405 · Cited by 2,052
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
The Methylation Effect in Medicinal Chemistry
Barreiro, E. J., Kümmerle, A. E., & Fraga, C. A. M. (2011) · Chemical Reviews · doi:10.1021/cr200060g · Cited by 1,017
Reactive Oxygen Species: Players in the Platelet Game
Krötz, F., Sohn, H.-Y., & Pohl, U. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000145574.90840.7d · Cited by 1,006
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
Metadata
- Authors
- FitzGerald, G. A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-11-01
- Volume
- 2
- Issue
- 11
- Pages
- 879-890
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2088179332
- Cited by
- 518
- References
- 124
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.